| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment | Metabolite | Tissue |
|---|---|---|---|---|---|---|---|
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.510 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.576 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.618 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.641 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.697 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.809 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.834 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.990 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 0.996 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.011 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.043 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.119 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.148 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.173 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.200 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.230 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.235 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.239 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.247 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.264 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.275 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.412 | mg/mL | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.428 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.463 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.467 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.493 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.498 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.591 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.610 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.620 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.669 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.676 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.682 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.698 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.728 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.781 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.795 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.816 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.879 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.905 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.996 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 1.996 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.008 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.042 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.054 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.217 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.329 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.346 | mg/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.364 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.491 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.519 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.600 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.651 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.662 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.675 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.685 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.744 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.758 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.958 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 2.999 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.041 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.042 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.191 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.208 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.313 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.383 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.457 | mg/mL | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.687 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.702 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.833 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 3.838 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 4.278 | mg/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 4.657 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 4.897 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 4.987 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 4.987 | mg/mL | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.334 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.399 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.494 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.513 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.531 | mg/mL | F344 Pirc | AIN-93G (control) | Fatty Acid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.541 | mg/g tissue | F344 Pirc | 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.641 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 5.909 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 6.045 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 6.099 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 6.189 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 6.308 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 7.213 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 7.328 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 7.857 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 8.179 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 8.396 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 9.939 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 10.174 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 10.297 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 11.074 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 12.019 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 14.582 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 15.917 | mg/g tissue | F344 Pirc | AIN-93G (control) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 16.158 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 17.471 | mg/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 19.192 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 20.323 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 21.958 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 23.966 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 43.991 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 49.989 | mg/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 50.509 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 149.808 | mg/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Fatty Acid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Palmitoleic acid | 185.366 | mg/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Fatty Acid | Tumor-adjacent normal colon |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|